Atossa Therapeutics
ATOS
#9237
Rank
โ‚ฌ88.67 M
Marketcap
0,69ย โ‚ฌ
Share price
5.24%
Change (1 day)
-40.55%
Change (1 year)

Atossa Therapeutics (ATOS) - Net assets

Net assets on the balance sheet as of June 2025 : โ‚ฌ49.55 Million

According to Atossa Therapeutics's latest financial reports the company has โ‚ฌ49.55 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Atossa Therapeutics - Net assets on balance sheet (from 2010 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚ฌ68.68 M-16.57%
2023-12-31$โ‚ฌ82.33 M-25.13%
2022-12-31$โ‚ฌ0.10 B-9.84%
2021-12-31$โ‚ฌ0.12 B452.22%
2020-12-31$โ‚ฌ22.08 M88.08%
2019-12-31$โ‚ฌ11.74 M52.58%
2018-12-31$โ‚ฌ7.69 M33.09%
2017-12-31$โ‚ฌ5.78 M96.4%
2016-12-31$โ‚ฌ2.94 M-13.96%
2015-12-31$โ‚ฌ3.42 M-56.18%
2014-12-31$โ‚ฌ7.8 M1.73%
2013-12-31$โ‚ฌ7.67 M96.2%
2012-12-31$โ‚ฌ3.91 M225.77%
2011-12-31$โ‚ฌ1.2 M-287.54%
2010-12-31$-โ‚ฌ0.65 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ68.09 B 137,307.05%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ7.48 B 15,001.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ6.33 B 12,684.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚ฌ37.27 M-24.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚ฌ0.72 B 1,352.97%๐Ÿ‡บ๐Ÿ‡ธ USA